Compare TERN & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TERN | CROX |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.9B |
| IPO Year | 2021 | 2006 |
| Metric | TERN | CROX |
|---|---|---|
| Price | $39.59 | $89.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $48.60 | ★ $100.92 |
| AVG Volume (30 Days) | ★ 4.9M | 1.3M |
| Earning Date | 11-10-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.26 |
| Revenue | N/A | ★ $4,072,780,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $27.52 |
| Revenue Growth | N/A | ★ 0.01 |
| 52 Week Low | $1.87 | $73.21 |
| 52 Week High | $48.26 | $122.84 |
| Indicator | TERN | CROX |
|---|---|---|
| Relative Strength Index (RSI) | 65.97 | 59.08 |
| Support Level | $25.67 | $88.39 |
| Resistance Level | $45.17 | $92.12 |
| Average True Range (ATR) | 3.71 | 2.84 |
| MACD | 0.08 | 0.26 |
| Stochastic Oscillator | 63.41 | 67.15 |
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company are the United States and other Countries.